ACCURAY INCORPORATED Income (Loss) Attributable to Noncontrolling Interest, before Tax
ACCURAY INCORPORATED (ARAY) reported Income (Loss) Attributable to Noncontrolling Interest, before Tax of $13.29 million for the 12-month period ending 2013-06-30, per its 10-K filed 2014-08-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToNoncontrollingInterest · last filed 2014-08-29
- ACCURAY INCORPORATED income (loss) attributable to noncontrolling interest, before tax for fiscal 2013 was $13.29M, a 107.28% increase from fiscal 2012.
- ACCURAY INCORPORATED income (loss) attributable to noncontrolling interest, before tax for fiscal 2012 was $6.41M.
| Period end | Income (Loss) Attributable to Noncontrolling Interest, before Tax 12 month |
|---|---|
| 2013-06-30 | $13.29M 10-K · filed 2014-08-29 |
| 2012-06-30 | $6.41M 10-K · filed 2014-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |